Ichilov Hospital and Sanara Ventures join forces to promote innovation in neurology
Sanara Ventures has identified significant medical and commercial potential at Ichilov’s Department of Neurology and will provide researchers with holistic and technological assistance. Additionally, global experts, who are part of the company’s global team, will help guide developing startups through the investment stages. This collaboration aims to help the various companies to take shape upstream, to receive financing and to realize their commercial and technological potential.
The Department of Neurology of the Ichilov Medical Center regularly conducts research and develops medical technologies in various fields, in areas such as diseases of the central nervous system, sleep disorders, neurological problems, neurological rehabilitation, stroke , cerebral rehabilitation and the treatment of cerebral and cognitive difficulties. These areas are in desperate need of more solutions and new technologies that will dramatically improve the lives of thousands of patients around the world.
Sanara Ventures, based in Ra’anana, invests in innovative digital medicine, medical equipment and bioconvergence projects. The company is a healthcare investment platform for innovative startups, comprising an incubator supported by the Israel Innovation Authority and includes global giants such as Philips Healthcare and Teva Pharmaceuticals. Its management team supports startups by providing them with pre-seed, seed and pre-A funding.
“Neurology is today one of the most important areas of clinical medical innovation and has made tremendous breakthroughs over the past 10 years. In addition to being synergistic for both Teva and Phillips in areas such as degenerative diseases and the central nervous system or sleep disorders, Sanara recognizes great potential in creating privileged links with clinical teams in these areas ” said Assaf Barnea, CEO of Sanara Ventures.
“Ichilov sees the improvement of medical technologies – with an emphasis on neurology – as a global goal in which we want to play an important role,” said the director of the department of neurology, Professor Nir Giladi.